Member Exclusive

Pharma is opening the doors for external molecule designers

The Open Innovation model is being explored by Pharma and it holds great promise for all parties in the Life Science ecosystem. In a move to further boost early drug discovery innovation several OI platforms in Pharma RnD have been established in order to allow external partner to much more easily test their molecules for biological activity.

Please sign in or register for FREE

No comments yet.